(0.83%) 5 124.50 points
(0.14%) 38 342 points
(1.12%) 17 764 points
(0.43%) $83.93
(-3.36%) $1.583
(0.31%) $2 349.80
(0.94%) $27.61
(1.15%) $931.10
(0.07%) $0.932
(0.10%) $10.96
(0.05%) $0.800
(-0.28%) $91.91
Live Chart Being Loaded With Signals
Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. It develops PRIMA System, a bionic vision system for patients with severe vision loss due to retinal degeneration caused by the dry atrophic form of Age-related Macular Degeneration (AMD); and to treat bilndness, which replace the normal physiological function of the eye's photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the visual information to the brain via the optic nerve...
Stats | |
---|---|
Today's Volume | 86 010.00 |
Average Volume | 362 912 |
Market Cap | 1.16M |
EPS | €0 ( 2024-04-18 ) |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -0.0471 |
ATR14 | €0.0810 (21.52%) |
Volume Correlation
Pixium Vision SA Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pixium Vision SA Correlation - Currency/Commodity
Pixium Vision SA Financials
Annual | 2022 |
Revenue: | €2 000.00 |
Gross Profit: | €-805 491 (-40 274.55 %) |
EPS: | €-0.200 |
Q2 | 2023 |
Revenue: | €445 000 |
Gross Profit: | €46 304.00 (10.41 %) |
EPS: | €-3.33 |
Q1 | 2023 |
Revenue: | €445 000 |
Gross Profit: | €445 000 (100.00 %) |
EPS: | €-1.670 |
Q4 | 2022 |
Revenue: | €454 500 |
Gross Profit: | €50 259.00 (11.06 %) |
EPS: | €-3.39 |
Financial Reports:
No articles found.
Pixium Vision SA
Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. It develops PRIMA System, a bionic vision system for patients with severe vision loss due to retinal degeneration caused by the dry atrophic form of Age-related Macular Degeneration (AMD); and to treat bilndness, which replace the normal physiological function of the eye's photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the visual information to the brain via the optic nerve. The company has collaboration agreements with Stanford University in California, Institut de la Vision, Moorfields Eye Hospital, Institute of Ocular Microsurgery, University Hospital, and UPMC. Pixium Vision SA was founded in 2011 and is based in Paris, France.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators